Evidence map›Paper›PMID 30328056›Full record

Trial reportJournal of cancer survivorship : research and practice2018

A smoking cessation and pain management program for cancer survivors.

Kathryn I Pollak, Laura J Fish, Linda M Sutton, Xiaomei Gao, Pauline Lyna, Lynda Owen, Michele L Patel, Tamara J Somers

Abstract readMulticenter StudyRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Journal of cancer survivorship : research and practice, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Psycho-oncology · 2020
    Pooled it
  2. Observational
  3. Article
  4. Article
  5. A scoping review of pain and tobacco use among cancer survivors.Annals of behavioral medicine : a publication of the Society of Behavioral Medicine · 2025
    Article
  6. Review
  7. Article
  8. Healthy Behaviors: Prevalence of Uptake Among Cancer Survivors.Clinical journal of oncology nursing · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kathryn I PollakCancer Control and Population Sciences, Duke Cancer Institute, Durham, NC, USA. kathryn.pollak@duke.edu.
Laura J FishCancer Control and Population Sciences, Duke Cancer Institute, Durham, NC, USA.
Linda M SuttonDuke Cancer Network, Duke Cancer Institute, Durham, NC, USA.
Xiaomei GaoCancer Control and Population Sciences, Duke Cancer Institute, Durham, NC, USA.
Pauline LynaCancer Control and Population Sciences, Duke Cancer Institute, Durham, NC, USA.
Lynda OwenDuke Cancer Network, Duke Cancer Institute, Durham, NC, USA.
Michele L PatelDepartment of Psychiatry and Behavioral Sciences, Duke School of Medicine, Durham, NC, USA.
Tamara J SomersCancer Control and Population Sciences, Duke Cancer Institute, Durham, NC, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeMany cancer survivors continue to smoke. Further, most survivors also report high levels of persistent pain and smoke in response to pain. The investigators tested the feasibility, acceptability, and preliminary efficacy of a smoking cessation program paired with a pain management program for cancer survivors.

methodsThe investigators conducted a two-arm, wait-list randomized controlled pilot study in which they delivered a combined smoking cessation and pain management intervention.

resultsThe investigators randomized 30 survivors (14 intervention and 16 wait-list control). Seventy-one percent of the survivors who received the intervention rated it as extremely useful (5 out of 5) in helping them quit smoking. Further, 86% would recommend the program to other survivors. Although we could not conduct inferential statistics, 14% of those in the intervention arm, compared to 6% in the control condition had biochemically validated cessation at 2-months post-randomization. Survivors in the intervention also reported less pain, had improvements in depressive symptoms, and better physical function than those in the control arm.

conclusionsOur pilot data suggest the feasibility, acceptability, and preliminary efficacy of this approach. The next step is to conduct a large randomized controlled trial to fully test the efficacy of the intervention. IMPLICATIONS FOR CANCER SURVIVORS: A combined smoking cessation and pain program might help improve both issues simultaneously.

Indexed as

Cancer SurvivorsAgedCombined Modality TherapyFemaleHealth BehaviorHumansMaleMiddle AgedPain ManagementPilot ProjectsSmokingSmoking CessationTobacco Use Cessation DevicesWaiting ListsCancerOncologyPainSmoking cessationSurvivors

Identifiers

PMID30328056

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.